New Delhi, April 27 -- Mumbai: From technology to automobiles to pharmaceuticals, Indian companies are scaling up their global ambitions like never before. They are using large acquisitions overseas to quickly scale, deliver higher value products and compete on the global stage. The latest one-Sun Pharmaceutical Industries Ltd's $11.75 billion acquisition of US-based specialty drugmaker Organon & Co, the largest overseas buyout by an Indian firm, caps a year of such bold bets.

Whether it is Coforge Ltd's $2.5 billion buyout of California-based Encora, Tata Motors Ltd's $4.5 billion bet on Italy's Iveco, or Bajaj Auto Ltd's $906 million acquisition of its long-time Austrian partner KTM, Indian companies are spending top dollar on acquirin...